| http://www.w3.org/ns/prov#value | - But in April 2010, Michael A. Brizzolara, then the president of Brioschi Inc., sent a letter to customers, vendors and other stakeholders saying his company would soon stop producing the brand, citing the rising cost of health care, increased costs, and large drug companies squeezing the company by placing a high priority on the antacid sector.
|
